Artículos del autor

solaci

Institutional News

Last Days to Sign Up to SOLACI-SOCIME 2022 with 15% OFF

LAST DAYS TO SIGN UP WITH 15% OFF We are a little less than one month away from the...
solaci -
Coronary disease

Same Day Discharge in NSTE-ACS: Is It Possible?

At present, percutaneous coronary intervention (PCI) is the most common coronary revascularization strategy. One of its benefits...
solaci -
Femoral

Thromboendarterectomy vs. Endovascular Therapy in Common Femoropopliteal Territory. Is Surgery Still the Gold Standard?

For lesions in the common femoral artery, guidelines recommend surgical endarterectomy (TEA) as the gold standard. However,...
solaci -
Femoropopliteal

Intermittent Claudication: Invasive Treatment Superior to Pharmacological Treatment?

Peripheral vascular disease is strongly associated to cardiovascular events and a negative impact on health status and...
solaci -
Institutional News

12/07 | SOLACI Webinar – Disruptive and Conventional Treatments in the SFA and BTK – Register Now

solaci -
Coronary disease

Is IVUS Guided PCI a Common Technique?

We all know the benefits of ultravascular ultrasound (IVUS) in the development of percutaneous coronary intervention, such...
solaci -
Antiplatelet

An Abbreviated Dual Antiplatelet Regimen Is Also Safe in Patients at High Risk for Bleeding Undergoing Complex Angioplasty

The MASTER DAPT study analyzed the results of an abbreviated (mean 34 days) vs. conventional dual antiplatelet...
solaci -
Antiplatelet

High Risk of Bleeding after PCI: More Evidence for Short DAPT

Dual antiaggregation therapy (DAPT) with ASA and P2Y12 during 6 to 12 months is the indicated strategy...
solaci -